Mandate

VINGE ADVISES ON OPUS GROUP’S RIGHTS ISSUE

February 13, 2015

Vinge is advising Opus Group in connection with a rights issue of approximately SEK 150 million. The rights issue is conditional upon approval by the members at an extraordinary general meeting to be held on 10 March 2015. The board of directors will determine the terms and conditions governing the rights issue not later five days prior to the record day. A prospectus is expected to be published on 11 March 2015 and the subscription period is 17-31 March 2015.

Vinge’s team advising on the preparation of the prospectus and capital markets issues consists of responsible partner Anders Strid together with associates Daniel Lennartsson, Frida Bäckgren and Anna Hofling Johansson (tax).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025